MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 02-12-2026
GBS General and Administrative Expenses 2011-2026 | GBS
General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.What these expenses include
- Salaries of administrative staff (executives, HR, accountants, legal personnel)
- Office rent and utilities
- Office equipment and IT infrastructure
- Professional services (auditors, lawyers, consultants)
- Insurance
- General administrative travel and representation expenses
- Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure - Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit - Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry - Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines
Annual General and Administrative Expenses GBS
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.88 M | 9.26 M | 8.03 M | 4.92 M | 3.36 M | 2.43 M | 3.55 M | 2.08 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 9.26 M | 2.08 M | 5.31 M |
Quarterly General and Administrative Expenses GBS
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.34 M | 2.66 M | - | 2.41 M | 1.81 M | 1.95 M | - | 2.43 M | 1.71 M | 2.46 M | - | 1.9 M | 2.25 M | - | 3.7 M | 1.12 M | 1 M | 1.33 M | 2.34 M | 1.01 M | 671 K | 521 K | 671 K | 53.8 K | 972 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.7 M | 53.8 K | 1.68 M |
General and Administrative Expenses of other stocks in the Medical devices industry
| Issuer | General and Administrative Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Alphatec Holdings
ATEC
|
499 M | $ 11.03 | 1.19 % | $ 1.66 B |  USA |
 |
AxoGen
AXGN
|
44.6 M | $ 32.49 | 1.67 % | $ 1.5 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
25.6 M | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
14.1 M | - | -26.83 % | $ 2.62 M | USA |
 |
Align Technology
ALGN
|
1.76 B | $ 175.31 | 1.25 % | $ 13.1 B | USA |
 |
AdaptHealth Corp.
AHCO
|
382 M | $ 12.36 | 1.56 % | $ 1.67 B | USA |
 |
Allied Healthcare Products
AHPI
|
7.11 M | - | 3.58 % | $ 2.21 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
40.2 M | - | - | $ 3.31 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
8.78 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
814 M | $ 282.75 | 1.3 % | $ 7.98 B | USA |
 |
Cytosorbents Corporation
CTSO
|
35.6 M | $ 0.57 | -6.38 % | $ 35.5 M | USA |
 |
BioSig Technologies
BSGM
|
67.5 M | - | 37.08 % | $ 85.7 M | USA |
 |
EDAP TMS S.A.
EDAP
|
5.9 M | $ 3.32 | 0.61 % | $ 124 M |  France |
 |
Conformis
CFMS
|
28.8 M | - | - | $ 16.4 M | USA |
 |
Bruker Corporation
BRKR
|
894 M | $ 38.08 | 1.3 % | $ 5.67 K | USA |
 |
Boston Scientific Corporation
BSX
|
6.89 B | $ 62.05 | 0.47 % | $ 91.9 B | USA |
 |
Apollo Endosurgery
APEN
|
20.6 M | - | - | $ 475 M | USA |
 |
Cardiovascular Systems
CSII
|
171 M | - | 0.15 % | $ 844 M | USA |
 |
ClearPoint Neuro
CLPT
|
16.5 M | $ 9.15 | 5.53 % | $ 259 M | USA |
 |
Dynatronics Corporation
DYNT
|
8.46 M | - | 14.99 % | $ 929 K | USA |
 |
Electromed
ELMD
|
39.3 M | $ 24.32 | 0.83 % | $ 206 M | USA |
 |
Helius Medical Technologies
HSDT
|
9.27 M | $ 1.88 | -0.49 % | $ 1.14 M | USA |
 |
CryoLife, Inc.
CRY
|
141 M | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
14.1 M | - | -20.74 % | $ 369 K | USA |
 |
Second Sight Medical Products
EYES
|
1.11 M | - | -0.97 % | $ 54.4 M | USA |
 |
Inogen
INGN
|
67.4 M | $ 6.53 | 3.08 % | $ 174 M | USA |
 |
IRIDEX Corporation
IRIX
|
7.73 M | $ 0.99 | -0.99 % | $ 16.8 M | USA |
 |
Aziyo Biologics
AZYO
|
15.1 M | - | 1.37 % | $ 20.5 M | USA |
 |
Soliton, Inc.
SOLY
|
8.46 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
4.88 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
8.5 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
18 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
14.7 M | - | - | $ 111 M |  Canada |
 |
OrthoPediatrics Corp.
KIDS
|
120 M | $ 16.43 | 2.88 % | $ 385 M | USA |
 |
LivaNova PLC
LIVN
|
549 M | $ 63.3 | 0.82 % | $ 3.45 B |  Britain |
 |
LENSAR
LNSR
|
45.2 M | $ 5.85 | 2.63 % | $ 70 M | USA |
 |
Globus Medical
GMED
|
1.18 B | $ 91.35 | 1.08 % | $ 12.4 B | USA |
 |
Butterfly Network
BFLY
|
39.8 M | $ 4.14 | 0.98 % | $ 876 M | USA |
 |
Intersect ENT, Inc.
XENT
|
98.6 M | - | - | $ 955 M | USA |
 |
BIOLASE
BIOL
|
10.2 M | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
43.5 M | $ 10.24 | 1.99 % | $ 367 M | USA |
 |
Myomo
MYO
|
14 M | $ 0.69 | 0.59 % | $ 28.9 M | USA |
 |
Inspire Medical Systems
INSP
|
625 M | $ 54.15 | 0.28 % | $ 1.59 B | USA |
 |
CONMED Corporation
CNMD
|
132 M | $ 36.61 | -0.35 % | $ 1.14 B | USA |
 |
NanoVibronix
NAOV
|
3.46 M | - | - | $ 1.08 M | USA |
 |
Integer Holdings Corporation
ITGR
|
212 M | $ 85.19 | 0.06 % | $ 2.96 B | USA |
 |
FONAR Corporation
FONR
|
23.5 M | $ 18.63 | -0.29 % | $ 122 M | USA |